Concepedia

William Avery

WA

Statistics

Publications

10

Citations

2.4K

H-Index

10

Active since

2002

Affiliations

Momenta Pharmaceuticals (United States)(Current)

Dana-Farber Cancer Institute

BioFormatix (United States)

Howard Hughes Medical Institute

Harvard University

William Avery is an author at Momenta Pharmaceuticals (United States) specializing in pharmacology, medicine, and oncology.

Publications per year

2002–2021

10

Publications

10

Synergistic drug combinations tend to improve therapeutically relevant selectivity

Joseph Lehár, Andrew Krueger, William Avery et al. · Nature Biotechnology · 2009 · 957 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Bcl2 Regulation by the Melanocyte Master Regulator Mitf Modulates Lineage Survival and Melanoma Cell Viability

Gaël McGill, Martin A. Horstmann, Hans R. Widlund et al. · Cell · 2002 · 746 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14

Definitive Hematopoiesis Requires the Mixed-Lineage Leukemia Gene

Patricia Ernst, Jill K. Fisher, William Avery et al. · Developmental Cell · 2004 · 264 citations · Full text

Life Sciences, Hematology, Molecular Biology +14

Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity

Nathaniel Washburn, Inessa Schwab, Daniel Ortiz et al. · Proceedings of the National Academy of Sciences · 2015 · 226 citations · Full text

Pharmacy, Immunology, Pharmacology +17

The Novel Combination of Chlorpromazine and Pentamidine Exerts Synergistic Antiproliferative Effects through Dual Mitotic Action

Margaret Lee, Lisa M. Johansen, Yanzhen Zhang et al. · Cancer Research · 2007 · 112 citations

Medicine, Oncology, Pharmacology +17

1–5 of 10